MarketInOut Stock Screener Log In | Sign Up

Universal Ibogaine Inc

OTC • Healthcare • Biotechnology • Quote as of 10/27/2026
Universal Ibogaine Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.0313 mln
Float303 mln
Earnings Date01/09/2026

Relative Strength

59 / 100
Slightly ahead

Debt / Equity

9.45
Extremely leveraged

Pre-Tax Margin

-88%
Severely loss-making

ROE

-161
Deeply negative

ROA

-9.46
Negative

Business Description

Universal Ibogaine is a Canadian company focused on helping people overcome addiction. It runs treatment clinics across Canada and conducts research to better understand how ibogaine can be used as a treatment option. The company is based in Calgary.

Key Fundamentals

EPS-0.00
ROE-161
RPS0.01
ROIC15.14
ROA-9.46
Interest Cover3.27
EBITDA, mln-0.08
EV / EBITDA-2.50
Revenue, mln0.77

Quote Details

Last 0.0001
Change 0 (0%)
Open 0.0001
Volume 16,666
Turnover 1.67
Average Volume 406,200

Financial Ratios

Pre-Tax Profit Margin-88
Leverage Ratio4.55
Current Ratio0.39
Price / Book1.17
Debt / Equity9.45
Price / Sales0.67

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 55 / 100   
1 Month -99.53% 0 / 100   
2 Months -99.62% 0 / 100   
6 Months -99% 1 / 100   
1 Year -99.31% 1 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog